Stryker将脊椎植入器业务出售给Viscoglilosi兄弟公司,并提名了新的首席财务干事。
Stryker sells its spinal implants business to Viscogliosi Brothers, also naming a new CFO.
Stryker是一家整形装置公司,将向VB Spine投资公司Viscogliosi Brothers出售其美国脊椎植入业务。
Stryker, an orthopedic device company, will sell its U.S. spinal implants business to investment firm Viscogliosi Brothers, forming VB Spine.
这笔交易预计将在2025年结束,其中包括Stryker在法国和其他国际市场的脊椎业务,目的是加强两家公司的工作重点和增长。
The deal, expected to close in 2025, includes Stryker's spine business in France and other international markets, aiming to enhance focus and growth for both companies.
Stryker还宣布了CFO Glenn Boehnlein的退休,并称Preston Wells为他的继任者,Q4销售额增加10%至64亿美元,净收入增加5%至30亿美元。
Stryker also announced CFO Glenn Boehnlein's retirement and named Preston Wells as his successor, with Q4 sales up 10% to $6.4 billion and net income up 5% to $3.0 billion.
该公司预测2025年销售增长率为8-9%。
The company forecasts 8-9% sales growth for 2025.